Adamas Pharmaceuticals Inc. buy Quitte
Start price
23.12.15
/
50%
€20.62
Target price
06.01.16
€23.36
Performance (%)
12.12%
End price
06.01.16
€23.12
Summary
This prediction ended on 06.01.16 with a price of €23.12. The BUY prediction by Quitte finished with a performance of 12.12%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Adamas Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 3,01 % | 1,44 % | 22,85 % | 50,83 % |
| iShares Nasdaq 100 | 3,01 % | 0,57 % | 37,06 % | 80,37 % |
| iShares Nikkei 225® | 4,14 % | 4,55 % | 53,86 % | 60,40 % |
| iShares S&P 500 | 2,38 % | 0,24 % | 29,01 % | 59,98 % |
Comments by Quitte for this prediction
In the thread Adamas Pharmaceuticals Inc. diskutieren
Erfolge bei Parkinson
Adamas Pharma: Phase-3-Studie zu ADS-5102 erzielt gewünschte Resultate
(Stop Loss Kurs erreicht)

